Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical disease

American Journal of Veterinary Research

Volumn 66, Issue 5, 2005, Pages 910-914

  Wagner, Robert A ^a   Piché, Claude A ^b   Jöchle, Wolfgang ^c   Oliver, Jack W ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b PR Pharmaceuticals Inc   (United States)

^c The University of Tennessee ^*  (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; COTRIMOXAZOLE; DESLORELIN ACETATE; ESTRADIOL; GONADORELIN DERIVATIVE; HYDROXYPROGESTERONE; PREDNISONE; UNCLASSIFIED DRUG;

ADRENAL CORTEX DISEASE; ADRENAL CORTEX TUMOR; ADRENAL GLAND; AGGRESSION; ANDROSTENEDIONE BLOOD LEVEL; ANESTHESIA; ANIMAL EUTHANASIA; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG RESPONSE; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FERRET; HAIR GROWTH; HISTOPATHOLOGY; HORMONAL REGULATION; HORMONE RESPONSE; INSULINOMA; LIVER METASTASIS; LONG TERM CARE; LYMPHOMA; MALE; NONHUMAN; PROGESTERONE BLOOD LEVEL; PROSTATITIS; PRURITUS; RECURRENT DISEASE; RELAPSE; SEXUAL BEHAVIOR; SLOW RELEASE FORMULATION; SURGICAL RISK; TUMOR NECROSIS; VULVA DISEASE;

ADRENAL CORTEX DISEASES; AGING; ANIMALS; DRUG IMPLANTS; FEMALE; FERRETS; GONADAL STEROID HORMONES; MALE; RECURRENCE; TRIPTORELIN;

ANIMALIA; MUSTELA; MUSTELA PUTORIUS FURO;

EID: 20444445911     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.910     Document Type: Article

References (17)

1. Rosenthal KL, Peterson ME. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism. J Am Vet Med Assoc 1996;209:1097-1102.
2. Wagner RA, Dorn DP. Evaluation of serum estradiol concentrations in alopecic ferrets with adrenal gland tumors. J Am Vet Med Assoc 1994;205:703-707.
3. Rosenthal KL, Peterson ME, Quesenberry KE, et al. Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991). J Am Vet Med Assoc 1993;203:271-275.
4. Weiss CA, Scott MV. Clinical aspects and surgical treatment of hyperadrenocorticism in the domestic ferret: 94 cases (1994-1996). J Am Anim Hosp Assoc 1997;33:487-493.
5. Shoemaker NJ, Schuurmans M, Moorman H, et al. Correlation between age at neutering and age at onset of hyperadrenocorticism in ferrets. J Am Vet Med Assoc 2000;216:195-197.
6. Schoemaker NJ, Teerds KJ, Mol JA, et al. The role of luteinizing hormone in the pathogenesis of hyperadrenocorticism in neutered ferrets. Mol Cell Endocrinol 2002;197:117-125.
7. Jallageas M, Boissin J, Mas N. Differential photoperiodic control of seasonal variations in pulsatile luteinizing hormone release in long-day (ferret) and short-day (mink) mammals. J Biol Rhythms 1994;9:217-231.
8. Brown SA. Neoplasia. In: Hillyer EV, Queesenberry KE, eds. Ferrets, rabbits, and rodents clinical medicine and surgery. Philadelphia: WB Saunders Co, 1997;100-101.
9. Rilianawati, Paukku TP, Kero J, et al. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin α-subunit promoter/simian virus 40 T-antigen fusion gene. Mol Endocrinol 1998; 12:801-809.
10. Murthy ASK, Brezak MA, Baez AG. Postcastrational adrenal tumors in two strains of mice: morphologic, histochemical, and chromatographic studies. J Natl Cancer Inst 1970;45:1211-1222.
11. Pabon JE, Li X, Lei ZM, et al. Novel presence of luteinizing hormone releasing hormone/chorionic gonadotropins receptors in human adrenal glands. J Clin Endocrinol Metab 1996;81: 2397-2400.
12. Wagner RA, Bailey EM, Schneider JF, et al. Leuprolide acetate treatment of adrenocortical disease in ferrets. J Am Vet Med Assoc 2001;218:1272-1274.
13. Plosker GL, Brogden RN. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone related disorders. Drugs 1994;48: 930-967.
14. Trigg TE, Wright PJ, Armour AF, et al. Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. J Reprod Fertil Suppl 2001;57:255-261.
15. Munson L, Bauman JE, Asa CS, et al. Efficacy of the GnRH analogue deslorelin for suppression of estrous cycles in cats. J Reprod Fertil Suppl 2001;57:269-273.
16. D'Occhio MJ, Aspden WJ. Endocrine and reproductive responses of male and female cattle to agonists of gonadotropins-releasing hormone. J Reprod Fertil Suppl 1999;54:101-114.
17. Zlotta AR, Schulman CC. Can survival be prolonged for patients with hormone-resistant prostate cancer? Lancet 2001;357: 326-327.